Sugamura K, Sakitani M, Hinuma Y
J Immunol Methods. 1984 Oct 26;73(2):379-85. doi: 10.1016/0022-1759(84)90413-7.
An adult T-cell leukemia virus (ATLV) producer cell line (TL-Su) derived from a healthy ATLV-carrier, was used for virus-induced transformation of normal human T-cells. The transformation was carried out on microplates by co-cultivation of a limiting number of normal peripheral blood leukocytes (PBL) as transformed target cells and 2 X 10(4)/well of TL-Su cells irradiated lethally. The frequency of establishment of transformed cell lines correlated with the dose of PBL. The transforming target cell number was estimated to be approximately one per 500 PBL by the microplate method using TL-Su effector cells. When 1 X 10(3) PBL per well were plated, more than 90% of wells showed immortalizing transformation of PBL. Twenty transformed cell lines obtained from microplates with 500 PBL per well were shown to be of T-cell lineage. Ten of them were defined as belonging to the helper/inducer T-cell subset with Leu 3a antigen, and 4 were demonstrated to be of the cytotoxic/suppressor T-cell subset with Leu 2a antigen. The transformed cells always expressed Tac and OKT9 antigens (considered to be IL2 and transferrin receptors respectively). ATLV antigens were also expressed in all these cell lines tested, but their molecular species detected by radioimmunoprecipitation varied regardless of PBL donors and T-cell subsets. We propose this microplate transformation method as an advantageous system for obtaining abundant T-cell lines and for screening their immunological functions.
一株源自健康成人T细胞白血病病毒(ATLV)携带者的ATLV产生细胞系(TL-Su),被用于病毒诱导的正常人T细胞转化。转化过程在微孔板上进行,将有限数量的正常外周血白细胞(PBL)作为转化靶细胞,与每孔2×10⁴个经致死剂量照射的TL-Su细胞共同培养。转化细胞系的建立频率与PBL的剂量相关。通过使用TL-Su效应细胞的微孔板法估计,转化靶细胞数约为每500个PBL中有一个。当每孔接种1×10³个PBL时,超过90%的孔显示PBL发生了永生化转化。从每孔接种500个PBL的微孔板中获得的20个转化细胞系显示为T细胞谱系。其中10个被定义为带有Leu 3a抗原的辅助/诱导性T细胞亚群,4个被证明是带有Leu 2a抗原的细胞毒性/抑制性T细胞亚群。转化细胞总是表达Tac和OKT9抗原(分别被认为是IL2和转铁蛋白受体)。在所有这些测试的细胞系中也都表达了ATLV抗原,但通过放射免疫沉淀检测到的其分子种类因PBL供体和T细胞亚群的不同而有所差异。我们提出这种微孔板转化方法是一种获取大量T细胞系并筛选其免疫功能的有利系统。